Abstract:Since their identification over twenty-five years ago, the plethora of cell-penetrating peptides (CPP) and their applications has skyrocketed. These 5 to 30 amino acid in length peptides have the unique property of breaching the cell membrane barrier while carrying cargoes larger than themselves into cells in an intact, functional form. CPPs can be conjugated to fluorophores, activatable probes, radioisotopes or contrast agents for imaging tissues, such as tumors. There is no singular mechanism for translocation of CPPs into a cell, and therefore, many CPPs are taken up by a multitude of cell types, creating the challenge of tumor-specific translocation and hindering clinical effectiveness. Varying strategies have been developed to combat this issue and enhance their diagnostic potential by derivatizing CPPs for better targeting by constructing specific cell-activated forms. These methods are currently being used to image integrin-expressing tumors, breast cancer cells, human histiocytic lymphoma and protease-secreting fibrosarcoma cells, to name a few. Additionally, identifying safe, effective therapeutics for malignant tumors has long been an active area of research. CPPs can circumvent many of the complications found in treating cancer with conventional therapeutics by targeted delivery of drugs into tumors, thereby decreasing off-target side effects, a feat not achievable by currently employed conventional chemotherapeutics. Myriad types of chemotherapeutics such as tyrosine kinase inhibitors, antitumor antibodies and nanoparticles can be functionally attached to these peptides, leading to the possibility of delivering established and novel cancer therapeutics directly to tumor tissue. While much research is needed to overcome potential issues with these peptides, they offer a significant advancement over current mechanisms to treat cancer. In this review, we present a brief overview of the research, leading to identification of CPPs with a comprehensive state-of-the-art review on the role of these novel peptides in both cancer diagnostics as well as therapeutics.

Advancement and application of novel cell-penetrating peptide in cancer management

Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer

Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics

[Advances in the research and application of cell penetrating peptides]

Penetrating peptides: Applications in drug delivery

Cell penetrating peptides: Highlighting points in cancer therapy

Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery

The role of cell‐penetrating peptides in potential anti‐cancer therapy

Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

Cell Penetrating Peptides in the Delivery of Biopharmaceuticals

Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

New generation of cell‐penetrating peptides: Functionality and potential clinical application

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Cell-penetrating peptides: tools for intracellular delivery of therapeutics

[Development of Cell-Penetrating Peptides As Vectors for Drug Delivery].

Recent Progress of Cell-Penetrating Peptides As New Carriers for Intracellular Cargo Delivery.

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application

Peptide cargo administration: current state and applications

Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade

Cell‐penetrating Peptides for Cancer Treatment: Current State and Future Directions